Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed + cisplatin concomitant radiochemotherapy for esophageal cancer
ChiCTR-TRC-09000568Phase 4Completed
- Sponsor
- Shandong Cancer Hospital
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pemetrexed and cisplatin in esophageal cancer, sponsored by Shandong Cancer Hospital. Primary endpoint: Response rate. Started Nov 2009; status: completed.
02
Drugs
pemetrexedcisplatin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on ChiCTR-TRC-09000568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000568.